Suppr超能文献

浸润性导管乳腺癌中的免疫组织化学肿瘤标志物

[Immunohistochemical tumor markers in infiltrating ductal breast carcinoma].

作者信息

Gallegos M, González S, León A, Claure R, Goñi I, Andrade L, Duarte I

机构信息

Departamento de Anatomía Patológica, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

出版信息

Rev Med Chil. 1998 Oct;126(10):1216-23.

Abstract

BACKGROUND

Immunohistochemical techniques allow the study of tumoral markers with predictive or prognostic value.

AIM

To study tumoral markers in mammary carcinoma and to relate these markers with age and tumoral histological grade.

MATERIAL AND METHODS

The expression of nuclear estrogen receptor (RE), nuclear progesterone receptor (PGR), p53 and c-erb-B2 proteins was analyzed in 382 cases of infiltrating ductal carcinoma of the breast.

RESULTS

The histological grade was I in 22% tumors, II in 56% and III in 23%. Forty nine percent of tumors had positive staining for RE, 41% for RPG, 45% for p53 and 57% for c-erb-B2. Correlation was found between histological grade and expression of RE, p53 and c-erb-B2 between RE and PGR, RE and c-erb-B2 and between c-erb-B2 and p5. RE expression correlated with age.

CONCLUSIONS

A reliable and rapid evaluation of these markers can be achieved using immunohistochemical staining. The present results are similar to other biochemical and immunohistochemical studies.

摘要

背景

免疫组织化学技术可用于研究具有预测或预后价值的肿瘤标志物。

目的

研究乳腺癌中的肿瘤标志物,并将这些标志物与年龄和肿瘤组织学分级相关联。

材料与方法

分析了382例乳腺浸润性导管癌中核雌激素受体(RE)、核孕激素受体(PGR)、p53和c-erb-B2蛋白的表达情况。

结果

22%的肿瘤组织学分级为I级,56%为II级,23%为III级。49%的肿瘤RE染色阳性,41%的PGR染色阳性,45%的p53染色阳性,57%的c-erb-B2染色阳性。发现组织学分级与RE、p53和c-erb-B2的表达之间,RE与PGR之间、RE与c-erb-B2之间以及c-erb-B2与p5之间存在相关性。RE表达与年龄相关。

结论

使用免疫组织化学染色可实现对这些标志物的可靠且快速的评估。目前的结果与其他生化和免疫组织化学研究相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验